Conference on Fontan-associated liver disease on 7 March 2024

Conference on Fontan-associated liver disease

On 7 March 2024, 15:00 – 17:00 CET a panel of international speakers show different perspectives (senior intensivist, cardiologist and surgeon) on this increasingly prevalent condition.

Fontan-type surgery is the final step in the palliative surgical treatment of infants born with a single heart ventricle. It carries long-term haemodynamic changes resulting in liver damage, leading to Fontan-associated liver disease (FALD). It is estimated that 1/10.000 children are born with this condition expecting that more than 70 million people worldwide will be affected in 2023. It translates into a real challenge for patients and physicians, often leading to a multidisciplinary approach in highly specialized healthcare institutions.

Learning objectives
To share different views amongst several transplant specialists to facilitate a better comprehension of cardiohepatic physiopathology and potential treatments.

Expected outcomes
Sensitize the medical community towards this condition and facilitate and improve its understanding.

Relevance of the event for the transplant community
It is an opportunity to hear from experts and improve individual knowledge, often limited given its complexity and prevalence.

Register here:
https://us06web.zoom.us/j/81208726505?pwd=OHsCfV-FviaO4F3u1Y0G4P38mgE7vw.nRBHCVfz8JeS6d7Z

Access code: 648234